HomeCompareMDLY vs MRK

MDLY vs MRK: Dividend Comparison 2026

MDLY yields 556.46% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDLY wins by $331.5K in total portfolio value
10 years
MDLY
MDLY
● Live price
556.46%
Share price
$5.88
Annual div
$32.72
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$388.2K
Annual income
$1,069.55
Full MDLY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MDLY vs MRK

📍 MDLY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDLYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDLY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDLY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDLY
Annual income on $10K today (after 15% tax)
$47,299.32/yr
After 10yr DRIP, annual income (after tax)
$909.12/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,419.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDLY + MRK for your $10,000?

MDLY: 50%MRK: 50%
100% MRK50/50100% MDLY
Portfolio after 10yr
$222.5K
Annual income
$5,433.84/yr
Blended yield
2.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MDLY
Analyst Ratings
3
Buy
5
Hold
Consensus: Hold
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDLY buys
0
MRK buys
0
No recent congressional trades found for MDLY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDLYMRK
Forward yield556.46%2.76%
Annual dividend / share$32.72$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$388.2K$56.8K
Annual income after 10y$1,069.55$9,798.13
Total dividends collected$235.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: MDLY vs MRK ($10,000, DRIP)

YearMDLY PortfolioMDLY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$38,523$27,823.13$11,206$366.19+$27.3KMDLY
2$91,305$50,085.70$12,650$502.35+$78.7KMDLY
3$153,169$55,472.17$14,407$694.19+$138.8KMDLY
4$207,375$43,484.60$16,585$967.82+$190.8KMDLY
5$249,403$27,511.11$19,342$1,363.89+$230.1KMDLY
6$282,322$15,461.03$22,913$1,947.19+$259.4KMDLY
7$310,263$8,178.40$27,662$2,823.89+$282.6KMDLY
8$336,181$4,199.91$34,159$4,173.35+$302.0KMDLY
9$361,841$2,126.52$43,337$6,308.80+$318.5KMDLY
10$388,239$1,069.55$56,776$9,798.13+$331.5KMDLY

MDLY vs MRK: Complete Analysis 2026

MDLYStock

Medley Management, Inc. provides investment management services. The company is headquartered in New York, New York and currently employs 76 full-time employees. The firm operates in the investment management segment. The company is focused on credit-related investment strategies, primarily originating senior secured loans to private middle market companies in the United States. The firm generally holds these loans to maturity. Its national direct origination franchise provides capital to the middle market in the United States. The firm has over $4.8 billion of assets under management (AUM) in approximately two business development companies (BDCs), Medley Capital Corporation (MCC) and Sierra Income Corporation (SIC), as well as private investment vehicles. The company has over $5 billion of AUM. The firm provides capital to over 300 companies across approximately 35 industries in North America. The firm's long-dated private funds include MOF I, MOF II and MOF III. Its private funds are managed through partnership structures

Full MDLY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MDLY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDLY vs SCHDMDLY vs JEPIMDLY vs OMDLY vs KOMDLY vs MAINMDLY vs JNJMDLY vs ABBVMDLY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.